Alberto Goizueta MD , Aileen Anglin APRN, ACNP-BC, AOCNP , Bruce F. Sabath MD
{"title":"一名 53 岁女性,患有 IV 期非小细胞肺癌,出现进行性气管旁淋巴结病。","authors":"Alberto Goizueta MD , Aileen Anglin APRN, ACNP-BC, AOCNP , Bruce F. Sabath MD","doi":"10.1016/j.chpulm.2024.100081","DOIUrl":null,"url":null,"abstract":"<div><h3>Case Presentation</h3><div>A 53-year-old woman with a history of <em>EGFR</em> mutation-positive stage IV lung adenocarcinoma underwent scheduled surveillance imaging. The disease was stable with osimertinib treatment for the preceding 24 months. Surveillance imaging noted new paratracheal adenopathy concerning for cancer progression. She was referred to interventional pulmonology for bronchoscopic evaluation. She provided written informed consent.</div></div>","PeriodicalId":94286,"journal":{"name":"CHEST pulmonary","volume":"2 4","pages":"Article 100081"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A 53-Year-Old Woman With Stage IV Non-Small Cell Lung Cancer and Progressive Paratracheal Lymphadenopathy\",\"authors\":\"Alberto Goizueta MD , Aileen Anglin APRN, ACNP-BC, AOCNP , Bruce F. Sabath MD\",\"doi\":\"10.1016/j.chpulm.2024.100081\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Case Presentation</h3><div>A 53-year-old woman with a history of <em>EGFR</em> mutation-positive stage IV lung adenocarcinoma underwent scheduled surveillance imaging. The disease was stable with osimertinib treatment for the preceding 24 months. Surveillance imaging noted new paratracheal adenopathy concerning for cancer progression. She was referred to interventional pulmonology for bronchoscopic evaluation. She provided written informed consent.</div></div>\",\"PeriodicalId\":94286,\"journal\":{\"name\":\"CHEST pulmonary\",\"volume\":\"2 4\",\"pages\":\"Article 100081\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"CHEST pulmonary\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2949789224000473\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"CHEST pulmonary","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949789224000473","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A 53-Year-Old Woman With Stage IV Non-Small Cell Lung Cancer and Progressive Paratracheal Lymphadenopathy
Case Presentation
A 53-year-old woman with a history of EGFR mutation-positive stage IV lung adenocarcinoma underwent scheduled surveillance imaging. The disease was stable with osimertinib treatment for the preceding 24 months. Surveillance imaging noted new paratracheal adenopathy concerning for cancer progression. She was referred to interventional pulmonology for bronchoscopic evaluation. She provided written informed consent.